Perindopril-Indapamide and Renal Function

Mechanism of Elevated Creatinine

• ACE inhibitors like perindopril can cause an initial rise in serum creatinine due to their effect on renal hemodynamics, particularly by reducing efferent arteriolar vasoconstriction, which decreases glomerular filtration pressure 1
• The combination with indapamide (a thiazide-like diuretic) can further impact renal function through volume depletion, potentially exacerbating the effect on creatinine levels 5

Expected Magnitude of Creatinine Elevation

• The ADVANCE trial, which specifically studied perindopril-indapamide combination, documented electrolyte abnormalities and elevated creatinine as adverse events 2, 4, 6

Risk Factors for Significant Creatinine Elevation

• Pre-existing chronic kidney disease, volume depletion or dehydration, concomitant use of NSAIDs or other nephrotoxic medications, high-grade bilateral renal artery stenosis or stenosis of a dominant kidney, aggressive diuretic therapy causing volume contraction, and heart failure with reduced cardiac output are risk factors for significant creatinine elevation 1

Clinical Implications and Management

• Monitoring of renal function is recommended at baseline and 1-2 weeks after initiation of therapy 1

Special Considerations

• Patients with diabetes may be particularly susceptible to changes in renal function but may also derive significant cardiovascular benefit from ACE inhibitor therapy 2, 4, 6
• The fixed-dose combination of perindopril-indapamide has been shown to reduce cardiovascular events in high-risk patients, including those with diabetes, despite the potential for creatinine elevation 4, 6, 5